BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu H, Li H, Jiao F, Han T, Zhuo M, Cui J, Li Y, Wang L. Association of a novel point mutation in MSH2 gene with familial multiple primary cancers. J Hematol Oncol 2017;10:158. [PMID: 28974240 DOI: 10.1186/s13045-017-0523-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Jiang H, Zhao S, Li G. Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report. Medicine (Baltimore) 2020;99:e23263. [PMID: 33217850 DOI: 10.1097/MD.0000000000023263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yi M, Dong B, Qin S, Chu Q, Wu K, Luo S. Advances and perspectives of PARP inhibitors. Exp Hematol Oncol 2019;8:29. [PMID: 31737426 DOI: 10.1186/s40164-019-0154-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
3 Liccardo R, De Rosa M, Izzo P, Duraturo F. Novel MSH2 splice-site mutation in a young patient with Lynch syndrome. Mol Med Rep 2018;17:6942-6. [PMID: 29568967 DOI: 10.3892/mmr.2018.8752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]